Skip to main content
S&P 5007,805.45-0.08%DOW51,670.10+0.03%NASDAQ27,204.38-0.15%BTC$83,383.00+2.60%ETH$2,506.39+3.61%GOLD$4,179.30+0.05%OIL$94.91+0.82%
Smart Investors Daily
SID Premium
AM

OTC · AMBBY

Ambu A/S

Healthcare · Medical - Devices

$11.00

Up+$0.00 (+0.00%)

Updated Oct 14, 2026, 8:44 AM

SID Score

4.8/10

Composite research score

Smart Money

46/100

Neutral

Market cap
3.34B
P/E ratio
39.19
Dividend yield
0.58%
52-week range
— – —
Volume
2
Avg. volume
234

Price performance · AMBBY

AMBBY price history

1M range · 0 trading sessions · Daily adjusted prices

AMBBY does not have enough price history for the selected period.

Data unavailable

The requested market data was not found.

Latest AMBBY news

The latest Smart Investors Daily articles mentioning AMBBY.

Stock researchCompany · Overview

AMBBY research

Overview

Company profile and research snapshot.

Company profile

AMBU A S UNSP/ADR

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
—
Implied upside
—
Analysts
—
AMBBY recent ratings
DateFirmRatingTarget
Sep 23, 2026ROTHSCHILD & CO REDBURNNeutral—
Aug 28, 2026DNB CARNEGIEBuy—
Jul 9, 2026ROTHSCHILD & CO REDBURNNeutral—
Jul 8, 2026ROTHSCHILD & CO REDBURNNeutral—
Jul 8, 2026DNB CARNEGIEBuy—
Open full forecast

News briefing

Generated Oct 13, 2026, 9:01 PM

What's Happening With AMBBY? Board Changes Spark Governance Questions

Ambu A/S faces renewed scrutiny as board restructuring efforts put corporate governance in the spotlight, raising investor questions about leadership direction and strategic oversight. The company's potential undervaluation is being weighed against concerns about management transitions and their implications for operational continuity.

    Bottom line: Ambu's board changes present both a near-term risk (uncertainty and potential execution disruption) and a potential opportunity (if governance improvements enhance strategic oversight). Investors should closely monitor the composition of the new board, management commentary on strategic priorities, and early indicators of operational continuity before taking a conviction stance on valuation.

    Yahoo · Oct 11, 2026

    Can Ambu (CPSE:AMBU B) Look Undervalued As Board Changes Put Governance In Focus?

    Boardroom shift puts governance in focus Ambu (CPSE:AMBU B) has drawn attention after appointing Jose Ignacio "Nacho" Abia as an observer to its Board of Directors, bringing experience from Grifols and more than two decades at Olympus. Recent trading has turned more upbeat for Ambu, with a 1-day share price return of 2.97%, a 7-day move of 8.17% and a 30-day gain of 11.39% from DKK72.85. However, the year-to-date share price return is down 15.54% and the 1-year total shareholder return has...

    AI research layers

    Interpretive context generated from the platform’s current data sources.

    No results

    AI research layers have not been published yet.

    Featured By